Calendar TME Pharma N.V.

Equities

Market Closed - Euronext Paris Other stock markets 11:29:56 2024-04-23 am EDT			5-day change	1st Jan Change
0.2565 ^EUR	+0.98%		-3.57%	+11.52%

08:00am	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI
Apr. 03	TME Pharma: Fast Track designation in glioblastoma	CF

65508fe7bbbf.SyoDF-720Shes6vaYV8Tn9dYD9GQGhcwWHtpPWXkk7s.AVlwX9yBn2xowuGLNh523r8cOIPWf3h4Phw9bhOS-dwdZlNCvLqOWT3s8g~4e6b2f18397959eab75a9600e2ac08ce

2024-04-23	Q4 2023 Earnings Release (Projected)
2024-10-23	Q2 2024 Earnings Release (Projected)
2025-04-22	Q4 2024 Earnings Release (Projected)
2025-10-22	Q2 2025 Earnings Release (Projected)

2024-03-25	Glioblastoma Development Summit
2024-03-17	Bio Europe Spring Conference
2023-11-17 10:30 pm	Society for Neuro Oncology Meeting
2023-10-27 12:00 pm	Q2 2023 Earnings Release
2023-10-21 05:15 am	European Society for Medical Oncology Congress
2023-06-29 07:30 am	Annual General Meeting
2023-06-03 02:15 pm	American Society of Clinical Oncology Conference - abstract #2048
2023-06-01	American Society of Clinical Oncology Conference
2023-04-24 12:00 pm	Q4 2022 Earnings Release
2023-01-30 07:30 am	Extraordinary Shareholders Meeting
2022-11-22 12:00 pm	Investor Meeting - Key Opinion Leader
2022-11-18 07:30 pm	Society for Neuro-Oncology Meeting - Abstract No: CTNI-67
2022-10-26 01:00 pm	Interim 2022 Earnings Release
2022-10-23	BIO Europe Conference
2022-09-20	Sachs Associates Biotech in Europe Forum
2022-09-08	ESMO Congress Conference
2022-06-29 08:00 am	Annual General Meeting
2022-06-10 08:00 am	Investor Meeting - Key Opinion Leader
2022-06-02	American Society of Clinical Oncology Meeting
2022-05-16 07:30 am	Extraordinary Shareholders Meeting

Fiscal Period	December	2018	2019	2020	2021	2022
Net sales Million EUR	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00	0,00 6,60 -	0,03 0,10 -66%
EBITDA Million EUR	Released Forecast Spread	-4,34 -4,70 7.57%	-3,90 -4,95 21.19%	0,00	-13,2 -5,20 -153.87%	-11,9 -16,3 26.77%
EBIT Million EUR	Released Forecast Spread	-4,37 -4,70 7.09%	-3,95 -5,05 21.82%	0,00	-13,3 -5,30 -150.32%	-12,0 -16,3 26.2%
Earnings before Tax (EBT)	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00	0,00 0,00 -	0,00 0,00 -
Net income Million EUR	Released Forecast Spread	-10,7 0,00 -	-0,86 -5,50 84.35%	-10,4	0,00 0,00 -	0,00 0,00 -
EPS EUR	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	-32,0	0,00 0,00 -	0,00 0,00 -
Announcement Date		12/04/19	22/04/20	28/04/21	22/04/22	24/04/23

2024-04-23	SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release
2024-04-23	MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected)
2024-04-23	CUREVAC N.V.: Q4 2023 Earnings Release
2024-04-23	ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release
2024-04-23	EVOTEC SE: Q4 2023 Earnings Release
2024-04-24 01:45 am	ADDLIFE AB: Q1 2024 Earnings Release
2024-04-24	PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release
2024-04-24	SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release
2024-04-24	HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release
2024-04-24	PURETECH HEALTH PLC: Q4 2023 Earnings Release

Today	SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
Today	HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release
Today	HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release
2024-04-22 04:15 pm	MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-17 02:07 am	TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report
2024-04-10 04:10 pm	PHARVARIS N.V.: Q4 2023 Earnings Release
2024-04-10 01:22 am	POLARIS GROUP: March 2024 Sales and Revenue Release
2024-04-02 02:30 am	ABIVAX: Q4 2023 Earnings Release
2024-04-01 09:00 am	BIOMEA FUSION, INC.: Q4 2023 Earnings Release
2024-03-28 10:42 pm	ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release